ATE554763T1 - Photodynamische therapie der mit der altersbezogenen makuladegeneration verbundenen okkulten chorioidalen neovaskularisation - Google Patents
Photodynamische therapie der mit der altersbezogenen makuladegeneration verbundenen okkulten chorioidalen neovaskularisationInfo
- Publication number
- ATE554763T1 ATE554763T1 AT02703362T AT02703362T ATE554763T1 AT E554763 T1 ATE554763 T1 AT E554763T1 AT 02703362 T AT02703362 T AT 02703362T AT 02703362 T AT02703362 T AT 02703362T AT E554763 T1 ATE554763 T1 AT E554763T1
- Authority
- AT
- Austria
- Prior art keywords
- age
- occult
- macular degeneration
- related macular
- chorioidal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26694001P | 2001-02-06 | 2001-02-06 | |
| PCT/US2002/003758 WO2002062386A2 (en) | 2001-02-06 | 2002-02-06 | Photodynamic therapy of occult choroidal neovascularization linked to age-related macular degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE554763T1 true ATE554763T1 (de) | 2012-05-15 |
Family
ID=23016614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02703362T ATE554763T1 (de) | 2001-02-06 | 2002-02-06 | Photodynamische therapie der mit der altersbezogenen makuladegeneration verbundenen okkulten chorioidalen neovaskularisation |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8034803B2 (de) |
| EP (1) | EP1357912B9 (de) |
| AT (1) | ATE554763T1 (de) |
| AU (1) | AU2002236988A1 (de) |
| CA (1) | CA2437563C (de) |
| ES (1) | ES2386718T3 (de) |
| WO (1) | WO2002062386A2 (de) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2436233C (en) * | 2001-01-30 | 2010-10-05 | Altachem Pharma Ltd. | Perylenequinones for use with immunotherapy agents |
| US7753943B2 (en) | 2001-02-06 | 2010-07-13 | Qlt Inc. | Reduced fluence rate PDT |
| US7060695B2 (en) | 2001-02-06 | 2006-06-13 | Qlt, Inc. | Method to prevent vision loss |
| US6800086B2 (en) | 2001-02-06 | 2004-10-05 | Qlt Inc. | Reduced fluence rate PDT |
| US7303578B2 (en) | 2001-11-01 | 2007-12-04 | Photothera, Inc. | Device and method for providing phototherapy to the brain |
| US20050159793A1 (en) * | 2002-07-02 | 2005-07-21 | Jackson Streeter | Methods for treating macular degeneration |
| WO2004034889A2 (en) * | 2002-10-18 | 2004-04-29 | The Regents Of The University Of California | Photodynamic therapy for ocular neovascularization |
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| WO2004080284A2 (en) * | 2003-03-07 | 2004-09-23 | Board Of Regents, The University Of Texas System | Antibody-targeted photodynamic therapy |
| US20060094753A1 (en) * | 2004-10-29 | 2006-05-04 | Alcon, Inc. | Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| US20060189582A1 (en) * | 2004-11-17 | 2006-08-24 | Mclaurin Joanne | Compositions and methods for treatment of disorders of protein aggregation |
| JP5205264B2 (ja) | 2005-08-10 | 2013-06-05 | クウェスト・ファーマテック・インコーポレイテッド | ペリレンキノン誘導体及びその使用 |
| WO2007119108A2 (en) * | 2005-10-13 | 2007-10-25 | Waratah Pharmaceuticals Inc. | Inositol derivatives and their uses in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence |
| US20070197452A1 (en) * | 2006-02-17 | 2007-08-23 | Mclaurin Joanne | Treatment of amyloid-related diseases |
| WO2007129221A2 (en) * | 2006-02-17 | 2007-11-15 | Waratah Parmaceuticals Inc | Compositions comprising an epi-inositol compounds and methods for treatment of disorders of protein aggregation |
| EP1996175A4 (de) * | 2006-03-09 | 2009-06-10 | Waratah Pharmaceuticals Inc | Cyclohexan-polyalkohol-formulierung zur behandlung von störungen der proteinaggregation |
| CA2652449A1 (en) * | 2006-05-19 | 2007-11-29 | Waratah Pharmaceuticals Inc. | Screening methods for amyloid beta modulators |
| US8454991B2 (en) | 2006-07-24 | 2013-06-04 | Quest Pharmatech Inc. | Method and device for photodynamic therapy |
| WO2008034244A1 (en) * | 2006-09-21 | 2008-03-27 | Waratah Pharmaceuticals Inc. | The combination of a cyclohexanehexol and a nsaid for the treatment of neurodegenerative diseases |
| WO2008061373A1 (en) * | 2006-11-24 | 2008-05-29 | Waratah Pharmaceuticals Inc. | Combination treatments for alzheimer's disease and similar diseases |
| RU2333022C1 (ru) * | 2007-03-05 | 2008-09-10 | Федеральное Государственное Учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию" | Способ фотодинамической терапии хориоидальных неоваскулярных мембран |
| CA2683548A1 (en) * | 2007-04-12 | 2008-10-23 | Joanne Mclaurin | Use of cyclohexanehexol derivatives for the treatment of polyglutamine diseases |
| US20100331267A1 (en) * | 2007-04-12 | 2010-12-30 | Mclaurin Joanne | Use of cyclohexanehexol derivatives in the treatment of alpha-synucleinopathies |
| EP2148667B1 (de) * | 2007-04-12 | 2013-05-22 | Waratah Pharmaceuticals, Inc. | Verwendung von cyclohexanhexol-derivaten bei der behandlung von augenerkrankungen |
| WO2008124931A1 (en) * | 2007-04-12 | 2008-10-23 | Joanne Mclaurin | Use of cyclohexanehexol derivatives in the treatment of amyotrophic lateral sclerosis |
| JP2012505162A (ja) * | 2008-10-09 | 2012-03-01 | ワラタ ファーマシューティカルズ， インコーポレイテッド | 黄斑変性症関連障害を処置するためのｓｃｙｌｌｏ−イノシトールの使用 |
| WO2011009020A2 (en) | 2009-07-16 | 2011-01-20 | Mallinckrodt Inc. | Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers |
| TWI775096B (zh) | 2012-05-15 | 2022-08-21 | 澳大利亞商艾佛蘭屈澳洲私營有限公司 | 使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd) |
| EP3800191B1 (de) | 2014-03-17 | 2025-08-20 | Adverum Biotechnologies, Inc. | Zusammensetzungen und verfahren zur verbesserten genexpression in zapfenzellen |
| HUE057653T2 (hu) * | 2014-12-11 | 2022-05-28 | Bayer Healthcare Llc | Kis aktív choroidális neurovaszkularizáció lézióval jellemzett idõskori makuladegeneráció kezelése |
| JP7095994B2 (ja) | 2015-03-02 | 2022-07-05 | アドヴェラム バイオテクノロジーズ， インコーポレイテッド | ポリヌクレオチドを網膜錐体に硝子体内送達するための組成物及び方法 |
| GB2545763A (en) | 2015-12-23 | 2017-06-28 | Adverum Biotechnologies Inc | Mutant viral capsid libraries and related systems and methods |
| US11519020B2 (en) | 2018-05-25 | 2022-12-06 | Regeneron Pharmaceuticals, Inc. | Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5798349A (en) * | 1994-03-14 | 1998-08-25 | The General Hospital Corporation | Use of green porphyrins to treat neovasculature in the eye |
| US5935942A (en) | 1994-12-14 | 1999-08-10 | Zeimer; Ran | Selective and non-invasive visualization or treatment of vasculature |
-
2002
- 2002-02-06 US US10/072,272 patent/US8034803B2/en not_active Expired - Lifetime
- 2002-02-06 AU AU2002236988A patent/AU2002236988A1/en not_active Abandoned
- 2002-02-06 AT AT02703362T patent/ATE554763T1/de active
- 2002-02-06 CA CA2437563A patent/CA2437563C/en not_active Expired - Lifetime
- 2002-02-06 ES ES02703362T patent/ES2386718T3/es not_active Expired - Lifetime
- 2002-02-06 EP EP02703362A patent/EP1357912B9/de not_active Expired - Lifetime
- 2002-02-06 WO PCT/US2002/003758 patent/WO2002062386A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1357912B1 (de) | 2012-04-25 |
| AU2002236988A1 (en) | 2002-08-19 |
| CA2437563C (en) | 2010-03-23 |
| CA2437563A1 (en) | 2002-08-15 |
| EP1357912A2 (de) | 2003-11-05 |
| ES2386718T3 (es) | 2012-08-28 |
| US20030087889A1 (en) | 2003-05-08 |
| US8034803B2 (en) | 2011-10-11 |
| EP1357912B9 (de) | 2012-06-13 |
| WO2002062386A3 (en) | 2002-10-24 |
| WO2002062386A2 (en) | 2002-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002236988A1 (en) | Photodynamic therapy of occult choroidal neovascularization linked to age-related macular degeneration | |
| AR037307A1 (es) | Metodos para el tratamiento de enfermedades oculares neovasculares | |
| TNSN05300A1 (en) | Treatment with anti-vegf antibodies | |
| WO2002096366A3 (en) | Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy | |
| PT1558616E (pt) | Porfirinas meso-substituídas | |
| WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
| CY1110721T1 (el) | Χρηση glp-2 σε συνδυασμο με αλλο θεραπευτικο παραγοντα σε οστικες παθησεις | |
| CY1106816T1 (el) | 1,5-δισυποκαταστημενες ενωσεις 3,4-διυδρο-1h-πυριμιδο [4,5-d] πυριμιδιν-2-ονης και η χρησιμοποιηση αυτων δια τη θεραπευτικη αγωγη ασθενειων εις τις οποιες μεσολαβει η csbp/p38 κιναση | |
| AU4550801A (en) | Herbal composition phy906 and its use in chemotheraphy | |
| CY1111999T1 (el) | Λακτοφερρινη στην αγωγη κακοηθων νεοπλασματων και αλλων υπερπλαστικων νοσων | |
| CY1108983T1 (el) | Μιμητικα της υπεροξειδικης δισμουτασης για την αγωγη οφθαλμικων διαταραχων και νοσων | |
| WO2003032900A3 (en) | Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications | |
| DE602004023183D1 (de) | Gegen antikörper gerichtete photodynamische therapie | |
| NO20024486D0 (no) | Forbedret behandling av neovaskularisering | |
| WO2003028629A3 (en) | Chlorin photosensitizing agents for use in photodynamic therapy | |
| NO20044530L (no) | Fremgangsmate for behandling av kognitive forstyrrelser | |
| BRPI0407693A (pt) | uso de esteróides para preparação de formulações utilizáveis no tratamento de pessoas sofrendo de distúrbios oculares, bem como formulação assim obtidos | |
| TR200101149T2 (tr) | Dış retina bozukluklarının tedavisi. | |
| WO2003028628A3 (en) | Photosensitizing carbamate derivatives | |
| MXPA04007443A (es) | Nuevos compuestos de porfirina-platino solubles en agua con alta selectividad tumoral y su uso para el tratamiento de enfermedades tumorales benignas y malignas. | |
| WO2003032902A3 (en) | Tumor targeted photodiagnostic-phototherapeutic agents | |
| AU2002234644A1 (en) | Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases | |
| ES2170479T3 (es) | Agente viral terapeutico que detiene el desarrollo de tumores. | |
| ES2181160T3 (es) | Derivados de 1,4-dihidropiridina y su utilizacion en terapia. | |
| ECSP993101A (es) | Metodo para el tratamiento de enfermedades neovasculares oculares |